Price $1.13 |
Market Cap
144.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
27.11
|
P/S
5.74
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-20.9K
|
FCF
-0.2
|
|
Op. Margin
-301.40%
|
Net Margin
-298.80%
|
ROE
-226.50%
|
ROI
-565.70%
|
|
ROA
-123.70%
|
EPS Growth
-15.70%
|
Current Ratio
0.6
|
Debt/Equity
25.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co (BMY) | $58.36 | - | 3.30% | 131.48B | Strong Buy |
| Pieris Pharmaceuticals Inc (PIRS) | $4.51 | - | - | 344.9M | Strong Buy |
| Assertio Holdings Inc (ASRT) | $1.02 | - | - | 40.3M | Strong Buy |
| Novo Integrated Sciences Inc (NVOS) | $1.73 | - | - | 48.7M | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $2.41 | - | - | 15.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
